Comparative serum protein binding of anthracycline derivatives

被引:43
作者
Chassany, O
Urien, S
Claudepierre, P
Bastian, G
Tillement, JP
机构
[1] HOP LA PITIE SALPETRIERE,MED ONCOL SERV,F-75013 PARIS,FRANCE
[2] UNIV PARIS 12,FAC MED,PHARMACOL LAB,F-94010 CRETEIL,FRANCE
关键词
anthracycline derivatives; serum protein binding; alpha(1)-acid glycoprotein; human serum albumin; hydrophobicity;
D O I
10.1007/s002800050529
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The binding of doxorubicin, iododoxorubicin, daunorubicin, epirubicin, pirarubicin, zorubicin, aclarubicin, and mitoxantrone to 600 mu M human serum albumin and 50 mu M alpha(1)-acid glycoprotein was studied by ultrafiltration at 37 degrees C and pH 7.4. Anthracycline concentrations (total and free) were determined by high-performance liquid chromatography (HPLC) with fluorometric detection. Binding to albumin (600 mu M) varied from 61% (daunorubicin) to 94% (iododoxorubicin). The binding to alpha(1)-acid glycoprotein (50 mu M) was more variable, ranging from 31% (epirubicin) to 64% (zorubicin), and was essentially related to the hydrophobicity of the derivatives. Simulations showed that the total serum binding varied over a broad range from 71% (doxorubicin) to 96% (iododoxorubicin).
引用
收藏
页码:571 / 573
页数:3
相关论文
共 9 条
[1]   MULTIPLE BINDING OF BEPRIDIL IN HUMAN-BLOOD [J].
ALBENGRES, E ;
URIEN, S ;
POGNAT, JF ;
TILLEMENT, JP .
PHARMACOLOGY, 1984, 28 (03) :139-149
[2]  
CHASSANY O, 1994, ANTICANCER RES, V14, P1
[3]  
EKSBORG S, 1982, CANCER CHEMOTH PHARM, V10, P7
[4]   BINDING OF VINCA ALKALOID ANALOGS TO HUMAN SERUM-ALBUMIN AND TO ALPHA-1-ACID GLYCOPROTEIN [J].
FITOS, I ;
VISY, J ;
SIMONYI, M .
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (03) :377-383
[5]  
MROSS K, 1990, EUR J CLIN PHARMACOL, V39, P507
[6]   EXTRACTION OF ANTHRACYCLINES FROM BIOLOGICAL-FLUIDS FOR HPLC EVALUATION [J].
ROBERT, J .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1980, 3 (10) :1561-1572
[7]   THE PLASMA-PROTEIN BINDING OF BASIC DRUGS [J].
ROUTLEDGE, PA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (05) :499-506
[8]  
STEWART CF, 1990, CANCER RES, V50, P6854
[9]  
URIEN S, 1988, BIOCHEM PHARMACOL, V147, P2964